You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thrombocythemia Myelofibrosis

Showing 51 - 75 of 412
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis Trial in United States (Simtuzumab, Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Scottsdale, Arizona
  • +6 more
Jun 17, 2020

Myelofibrosis Trial in Rochester, Firenze (APLIDIN (plitidepsin))

Completed
Has Results
  • Myelofibrosis
  • APLIDIN (plitidepsin)
  • Rochester, Minnesota
  • +1 more
Sep 17, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in United States (PU-H71, Ruxolitinib)

Terminated
  • Myelofibrosis
  • +3 more
  • New Haven, Connecticut
  • +9 more
Oct 19, 2020

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Los Angeles, California
  • +5 more
Jan 27, 2023

Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

Unknown status
  • Essential Thrombocythemia
  • +2 more
  • Diagnostic (18F-FLT PET/CT)
  • Doha, Qatar
    National Center for Cancer Care & Research (NCCCR)
Sep 27, 2020

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +121 more
Oct 21, 2021

Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF) Trial

Completed
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Los Angeles, California
  • +47 more
Apr 1, 2020

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Anchorage, Alaska
  • +172 more
Dec 1, 2022

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Myelofibrosis, Primary Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Worldwide (parsaclisib, ruxolitinib,

Recruiting
  • Myelofibrosis
  • +3 more
  • Berkeley, California
  • +176 more
Dec 1, 2022

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +80 more
Sep 25, 2020

Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Phoenix, Arizona
  • +166 more
Jan 27, 2022

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Vienna, Austria
  • +19 more
Apr 28, 2020

MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib)

Completed
Has Results
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +37 more
Jan 17, 2020

Chronic Myeloproliferative Disorders, Secondary Myelofibrosis Trial in Rochester (CC-4047)

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • Secondary Myelofibrosis
  • Rochester, Minnesota
    Mayo Clinic
Dec 16, 2019

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Terminated
    • Essential Thrombocythemia
    • +3 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Aug 10, 2020

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Completed
    • Primary Myelofibrosis
    • +2 more
    • Phoenix, Arizona
    • +113 more
    Apr 13, 2020

    Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia:

    Completed
    • Polycythemia Vera
    • +2 more
      • Salt Lake City, Utah
        University of Utah
      Oct 14, 2019

      Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

      Recruiting
      • Primary Myelofibrosis (PMF)
      • +2 more
      • Birmingham, Alabama
      • +155 more
      Aug 12, 2022

      Hepatomegaly, Myelofibrosis Transformation in Essential Thrombocythemia, Polycythemia Vera, Post-Polycythemic Myelofibrosis

      Terminated
      Has Results
      • Hepatomegaly
      • +4 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Apr 23, 2019